The Healthcare segment provides a comprehensive suite of products and services designed to prevent infection and improve patient outcomes in healthcare settings. This includes surgical equipment, sterile processing equipment, and endoscope reprocessing systems. Research and development efforts focus on improving sterilization technologies, developing advanced cleaning solutions, and enhancing surgical workflow efficiency. Technologies used include advanced sterilization methods like peracetic acid systems and germicidal ultraviolet light solutions. The segment addresses a broad range of therapeutic areas, including surgery, endoscopy, and sterile processing. Patient impact is significant, as these products and services directly contribute to patient safety and reduce the risk of healthcare-associated infections. STERIS's market positioning is strong, with a focus on innovation and regulatory compliance. Future opportunities include expanding into emerging markets and developing new solutions for the evolving needs of healthcare providers. The segment is subject to stringent regulatory requirements, including FDA approval for medical devices and sterilization processes. Partnerships with companies like GE Healthcare and NeuroLogica Corp. enhance the segment's offerings and market reach.

The Life Sciences segment focuses on providing sterilization and contamination control solutions for pharmaceutical, biotechnology, and medical device manufacturers. This segment offers contract sterilization services, including gamma irradiation, electron beam irradiation, and ethylene oxide sterilization. Research and development activities are centered on developing advanced sterilization methods, ensuring product safety, and meeting stringent regulatory requirements. Technologies used include various sterilization techniques and quality control systems. The segment supports the manufacturing of pharmaceuticals, biologics, and medical devices, impacting patient health by ensuring the sterility and safety of these products. STERIS's market position is strong due to its expertise in sterilization and its ability to meet the complex needs of the life sciences industry. Future opportunities include expanding sterilization capacity and developing new solutions for emerging therapies. The segment is subject to rigorous regulatory oversight, including FDA and other international regulatory bodies. Partnerships and collaborations are crucial for expanding service offerings and reaching new markets.

STERIS Isomedix Services provides contract sterilization services, including gamma irradiation, electron beam irradiation, and ethylene oxide sterilization. This segment focuses on providing sterilization services to the medical device, pharmaceutical, and food industries. Research and development efforts are focused on improving sterilization processes, ensuring product safety, and meeting regulatory requirements. Technologies used include advanced sterilization methods and quality control systems. The segment supports the manufacturing of medical devices, pharmaceuticals, and food products, impacting patient health and consumer safety by ensuring the sterility of these products. STERIS's market position is strong due to its expertise in sterilization and its ability to meet the complex needs of various industries. Future opportunities include expanding sterilization capacity and developing new solutions for emerging markets. The segment is subject to rigorous regulatory oversight, including FDA and other international regulatory bodies. Partnerships and collaborations are crucial for expanding service offerings and reaching new markets.